Atrium Health University City (biopsy only) — Charlotte, North Carolina

Atrium Health University City (biopsy only) is a clinical research site located in Charlotte, North Carolina, United States 28262.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Atrium Health University City (biopsy only) has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Urothelial Carcinoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Atrium Health University City (biopsy only)?

Atrium Health University City (biopsy only) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Atrium Health University City (biopsy only) conducted?

Atrium Health University City (biopsy only) has 2 clinical trials on record, with 2 currently active. Their work covers HER2-positive Breast Cancer, Urothelial Carcinoma.

Is Atrium Health University City (biopsy only) accredited by Crixeo Health?

Atrium Health University City (biopsy only) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Atrium Health University City (biopsy only)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.